Position in GILD
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$77,629
+$9,263 QoQ
Shares Held
557
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ANTIPODES PARTNERS Ltd holds $183,532,568 across 5 Drug Manufacturers - General names.
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $77,629 | 557 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $68,366 | 557 | Shares | Sole | 2026-02-05 | |
| 2025-03-31 | $120,789 | 1,078 | Shares | Sole | 2025-05-06 | |
| 2023-03-31 | $99,940,517 | 1,204,538 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $113,042,214 | 1,316,741 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $65,810,892 | 1,066,800 | Shares | Sole | 2022-11-10 | |
| 2020-09-30 | $22,458,421 | 355,411 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $69,079,963 | 897,842 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $66,563,836 | 890,367 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||